Publications financières Archive - Ose Immunotherapeutics - Société de biotechnologie intégrée qui développe des immunothérapies innovantes

First-half 2024 semester report (in French)

2023 Universal registration document

Auditors’s report on first-half 2023 financial report (in French)

First-half 2023 financial report (in French)

2022 Universal registration document

Statutory Auditors’ report on the condensated half-year financial statements (in French)

First-half 2022 financial report

2021 Universal registration document

First-half 2021 financial report

2020 Universal registration document